Top 9 Retatrutide OEM Service Companies Ranked for Custom Manufacturing and Quality

News related to:Top 9 Retatrutide OEM Service Companies 2026 · 3 min read

CALIFORNIA, CALIFORNIA, UNITED STATES, November 15, 2026 /CourierPR/ -- Retatrutide, an investigational once-weekly triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors, continues to draw clinical research interest for its potential in weight loss, obesity, weight management, diabetes, glucose control, and metabolic disorders. According to Eli Lilly, the company plans to submit a Biologics License Application for retatrutide to the FDA in the first quarter of 2027. IQVIA forecasts that the global obesity medicines market will reach $92 billion by 2026.

Eli Lilly reported that retatrutide 12 mg achieved an average weight loss of 20.8% over 80 weeks in adults with type 2 diabetes and obesity in the TRIUMPH-2 clinical trial. This disclosure has increased attention on the raw material, powder, and lyophilized powder of retatrutide, as well as the need for high-purity testing and GMP documentation.

The editorial ranking compares nine companies across five sourcing routes: direct OEM/ODM manufacturing, GMP API and CDMO supply, private-label lot supply, wholesale research material, and development-stage scale-up. The ranking is not an official market ranking or a regulatory approval list, but rather a comparison based on the available evidence.

Rank 1: Bachem (Switzerland) Bachem, a Switzerland-based peptide manufacturer with decades of experience in GMP peptide APIs and custom peptides for clinical and commercial use, is ranked first for its regulatory-grade custom manufacturing capabilities. Publicly described strengths include large-scale GMP production capacity, strong regulatory credentials, and batch-to-batch reproducibility. Buyers prioritizing documented process control and clinical-to-commercial continuity may place Bachem at the top of the review. However, the company did not detail Retatrutide-specific OEM terms and small-lot flexibility, so buyers should confirm project scope, minimum quantities, and timelines directly.

Rank 2: Xi’an Yihui Kangyuan Bio-technology Co., Ltd. (China) Xi’an Yihui Kangyuan Bio-technology Co., Ltd., a China-based peptide API and CDMO supplier, is ranked second for its cGMP peptide lines and approximately 500 kg annual capacity. The company reports nearly 20 years of R&D experience and a focus on GLP-1 peptides such as Retatrutide, Tirzepatide, and Semaglutide. Its profile makes it relevant to buyers who need Retatrutide raw material at larger scale or a contract development path rather than a packaging-led OEM order.

Rank 3: Langfang Jiwei Medical Technology Co., Ltd. (Jiwei) (China) Langfang Jiwei Medical Technology Co., Ltd. (Jiwei), a China-based manufacturer, is ranked third for its OEM/ODM capability, which covers logo and dose customization, a monthly capacity of 50,000 pieces, MOQ from 50 boxes, and a lead time of about two weeks. Quality control includes 100% inspection before shipment and an at least 99% purity test. The company cites a GMP certificate CN20180070 issued by the China Food and Drug Administration, valid to 2027, covering small volume parenteral solutions and lyophilized powder for injection. Retatrutide-specific GMP authorization was not independently verified.

Rank 4: PepNova (China) PepNova, a China-based supplier of Retatrutide lyophilized powder and peptide API, is ranked fourth for its in-house solid-phase synthesis with at least 99% purity, full-release QC using HPLC and MS, stable supply from gram to kilogram, factory-direct pricing, and flexible MOQ from research to commercial scale. Buyers comparing high-purity Retatrutide options will find PepNova’s combination of analytical release testing and scalable lot sizes relevant.

Rank 5: Pepti (PeptiGLP1) (China) Pepti (PeptiGLP1), a China-based supplier of GLP-1 raw materials including Retatrutide in powder or lyophilized vial form, operates its own Guangzhou facility and publishes lot-by-lot COA with HPLC purity and MS identity. Its service scope includes raw peptide powder, OEM/private-label packaging, and one-roof synthesis, purification, lyophilization, and filling. This makes Pepti relevant to buyers who want a single partner for Retatrutide powder handling and private-label presentation.

Rank 6: Ruite Peptide (China) Ruite Peptide, a China-based peptide supplier, focuses on high-purity Retatrutide and GLP-1 peptides. It reports a GMP-certified workshop, full QC documentation covering COA, HPLC, and MS, and capacity of more than 100 kg annual output. Delivery is described as 7-15 days, and the company supports OEM/ODM export to more than 30 countries. Ruite ranks sixth for its quality documentation, output scale, and export-oriented OEM/ODM service.

Rank 7: Winhycare Pharma (India) Winhycare Pharma, an India-based supplier of peptide APIs including Retatrutide, Tirzepatide, and Semaglutide, states that it supplies European, US, and globally licensed manufacturers and provides a COA with every batch. Its semaglutide portfolio is supported by US-DMF Type II and CTD Module 3 documentation.

Start filing today

One press release free every week. No card required.

Create a free account